Medicalgorithmics Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Kris Siemionow
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 1.4yrs |
Recent management updates
Recent updates
A Look At The Intrinsic Value Of Medicalgorithmics S.A. (WSE:MDG)
Oct 11
Would Medicalgorithmics (WSE:MDG) Be Better Off With Less Debt?
Sep 08What Is Medicalgorithmics S.A.'s (WSE:MDG) Share Price Doing?
Aug 15Is Medicalgorithmics (WSE:MDG) A Risky Investment?
Sep 20These 4 Measures Indicate That Medicalgorithmics (WSE:MDG) Is Using Debt Reasonably Well
Jun 14Medicalgorithmics (WSE:MDG) Is Posting Solid Earnings, But It Is Not All Good News
May 04Is Medicalgorithmics (WSE:MDG) A Risky Investment?
Mar 09CEO
Kris Siemionow
Dr. Krzysztof Siemionow, M.D., Ph D., also known as Kris, serves as President of Management Board and CEO at Medicalgorithmics S.A. since 2025 and served as Supervisory Board Member since November 2022 unt...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President of the Management Board & CEO | less than a year | no data | no data | |
| Chief Operating Officer | 1.8yrs | zł482.00k | 0.030% PLN 96.4k | |
| Chief Technology Officer | 1.8yrs | zł385.00k | 0.030% PLN 96.1k | |
| CFO & Member of the Management Board | less than a year | no data | no data | |
| Chief Scientific Officer | no data | no data | no data | |
| Director of Investor Relations | no data | no data | no data | |
| Marketing Manager | less than a year | no data | no data |
Experienced Management: MDG's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Vice Chairman of the Supervisory Board | 4.8yrs | zł172.00k | no data | |
| Member of the Supervisory Board | 1.4yrs | zł84.00k | no data | |
| Supervisory Board Member | 3yrs | no data | no data | |
| Chairman of the Supervisory Board | less than a year | no data | no data | |
| Member of the Supervisory Board | less than a year | no data | no data |
Experienced Board: MDG's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/27 19:37 |
| End of Day Share Price | 2025/11/27 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medicalgorithmics S.A. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Kowollik | East Value Research GmbH |
| Lukasz Kosiarski | Ipopema Securities S.A. |
| Tomasz Sokolowski | Santander Brokerage Poland |